Bain Capital sells ₹289 crore worth stake in Emcure Pharma via block deal; shares down 3.7%

Boston-based investment giant, Bain Capital-owned entity, BC Investments IV Ltd, sold ₹289 crore worth of stake in Emcure Pharmaceuticals through a block deal on the open market, according to the data collected from the NSE website.

After the stake sale, Emcure Pharma’s shares lost 3.75% to their intraday low of ₹1,665 during Thursday’s market session, according to the exchange data.

NSE data showed that on April 29, BC Investments IV Ltd sold 18 lakh shares of Emcure Pharma at an average trade price of ₹1,608.20 per share, which was purchased by Norges Bank on account of the Government Pension Fund Global.

BC Investments 18 lakh share sale transaction is worth ₹289.44 crore at the executed trade price in the block deal.

Emcure Pharma Q4 results date

In an exchange filing on April 28, Emcure Pharma announced that the company will release its audited standalone and consolidated financial statements for the year ended 2025-26 on Tuesday, May 5, 2026.

The pharma company’s earnings call is scheduled to be held at 3:30 pm (IST), as per the NSE filing.

In its Q3 results, Emcure Pharma posted a 48% rise in its net profit after tax (PAT) to ₹231 crore, compared year-on-year with ₹156 crore in the same period a year ago, as per the exchange filing.

The company’s revenue from core operations witnessed a 20% rise to ₹2,363 crore in the March quarter of the fiscal year ended 2025-26, compared with ₹1,962 crore in the same period a year ago.

Emcure Pharma’s earnings per share (EPS) improved to ₹12.16 apiece in the fourth quarter, compared to ₹8.12 per share in the same period a year earlier.

Emcure Pharma share price

As of 12:35 pm, Emcure Pharma shares were trading 3.2% lower at ₹1,674.70 during Thursday’s trading session, compared to ₹1,729.90 at the previous market session, according to the NSE data.

Emcure Pharma shares have delivered more than 63% returns in the past one year, and over 18% returns so far in 2026, as per the exchange data. The company’s shares have gained 4.5% in the past one month, and were trading over 4% higher in the last five market sessions.

Shares of the company hit its 52-week high of ₹1,768 on April 29, 2026, while the 52-week low was at ₹983 on May 9, 2025, according to the NSE data. The company’s market capitalisation (M-Cap) was trading around ₹31,611.45 crore as of Thursday, April 30.